CAMEL

NCT03134872 📎

Regimen

Experimental
camrelizumab + carbo + pem
Control
carbo + pem

Population

Chinese 1L non-sq NSCLC

Key finding

mPFS 11.3 vs 8.3 mo, HR 0.60 (0.45-0.79); camrelizumab 1L non-sq

Source: PMID 33347829

Timeline

  • Enrollment start: 2017-05-12 📎

Guideline citations

  • CSCO NSCLC 2025 ⚠️ OCR source